The last word to new FDA draft guidance for cancer clinical trial eligibility criteria for patients with incurable cancer

被引：0
|
作者：
Lythgoe, Mark P. [1 ]
Prasad, Vinay [2 ]
机构：
[1] Imperial Coll London, Hammersmith Hosp, Dept Surg & Canc, Du Cane Rd, London W12 0HS, England
[2] Univ Calif San Francisco, 550 16th St,2nd Fl, San Francisco, CA 94158 USA
来源：
JOURNAL OF CANCER POLICY | 2022年 / 31卷
关键词：
D O I：
10.1016/j.jcpo.2022.100322
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] A New Approach to Simplifying and Harmonizing Cancer Clinical Trials-Standardizing Eligibility Criteria
    Gerber, David E.
    Singh, Harpreet
    Larkins, Erin
    Ferris, Andrea
    Forde, Patrick M.
    Selig, Wendy
    Roy, Upal Basu
    JAMA ONCOLOGY, 2022, 8 (09) : 1333 - 1339
  • [32] Potential Impact of Revised NCI Eligibility Criteria Guidance Prior Malignancy Exclusion in Breast Cancer Clinical Trials
    Perez, Matthew
    Murphy, Caitlin C.
    Pruitt, Sandi L.
    Rashdan, Sawsan
    Rahimi, Asal
    Gerber, David E.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2022, 20 (07): : 792 - +
  • [33] A systematic review of eligibility criteria for phase II clinical trials for patients with lung cancer
    Doherty, Gary
    Ogunmwonyi, Innocent
    Shotton, Rohan
    BRITISH JOURNAL OF CANCER, 2018, 119 (11) : 46 - 46
  • [34] Eligibility criteria in clinical trials in breast cancer: a cohort study
    Szlezinger, Katarzyna
    Pogoda, Katarzyna
    Jagiello-Gruszfeld, Agnieszka
    Klosowska, Danuta
    Gorski, Andrzej
    Borysowski, Jan
    BMC MEDICINE, 2023, 21 (01)
  • [35] Eligibility criteria in clinical trials in breast cancer: a cohort study
    Katarzyna Szlezinger
    Katarzyna Pogoda
    Agnieszka Jagiełło-Gruszfeld
    Danuta Kłosowska
    Andrzej Górski
    Jan Borysowski
    BMC Medicine, 21
  • [36] New FDA guidance recommends increasing the number of older adults in cancer clinical trials
    O'Rourke, Kate
    CANCER, 2022, 128 (13) : 2397 - 2398
  • [37] Uptake of recommendations for broadening clinical trial eligibility criteria for patients with brain metastasis and leptomeningeal disease in lung cancer clinical trials: A systematic review
    Riano, Ivy
    Velez, Maria Antonia
    Pomares-Millan, Hugo
    Manana, Ana I. Velazquez
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [38] US FDA draft Guidance Standard for Clinical Trial Imaging Endpoints: more than just imaging?
    Walovitch, Richard C.
    Chokron, Patrick
    Agarwal, Sheela
    BIOMARKERS IN MEDICINE, 2012, 6 (06) : 839 - 847
  • [39] Lung Cancer Patients Should Have Better Access to Clinical Research: Relax the Eligibility Criteria
    Freeman-Daily, J.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S139 - S139
  • [40] Eligibility Criteria Perpetuate Disparities in Enrollment and Participation of Black Patients in Pancreatic Cancer Clinical Trials
    Riner, Andrea N.
    Girma, Selamawit
    Vudatha, Vignesh
    Mukhopadhyay, Nitai
    Skoro, Nevena
    Gal, Tamas S.
    Freudenberger, Devon C.
    Herremans, Kelly M.
    George, Thomas J.
    Trevino, Jose G.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (20) : 2193 - +
12345